Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-17 Vasista Vittal Chief Financial Officer Sale −2,394 $50.00 $120K 222,321
2020-01-17 HAYDEN DONALD J JR Director Option exercise +3,200 $0.85 $3K 3,200
2020-01-17 HAYDEN DONALD J JR Director Sale −3,200 $50.01 $160K 0
2020-01-17 HAYDEN DONALD J JR Director Option exercise · Stock Option (Right to Buy) −3,200 155,900
2020-01-14 HAYDEN DONALD J JR Director Option exercise +30,000 $0.85 $26K 30,000
2020-01-14 HAYDEN DONALD J JR Director Sale −30,000 $45.60 $1.4M 0
2020-01-14 HAYDEN DONALD J JR Director Option exercise · Stock Option (Right to Buy) −30,000 159,100
2020-01-08 Vasista Vittal Chief Financial Officer Option exercise +3,000 $13.09 $39K 232,215
2020-01-08 Vasista Vittal Chief Financial Officer Sale −2,400 $41.40 $99K 229,815
2020-01-08 Vasista Vittal Chief Financial Officer Sale −5,100 $41.92 $214K 224,715
2020-01-08 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −3,000 29,374
2020-01-02 Christmas Patrick J. SVP, General Counsel Grant or award · Stock Option (Right to Buy) +50,000 50,000
2020-01-02 Simpson Curran SVP, Product Development & CTO Grant or award · Stock Option (Right to Buy) +46,000 46,000
2019-12-31 Danos Olivier Chief Scientific Officer Grant or award +302 $34.82 $11K 6,802

Page 25 of 25 · 494 trades